Skip to Content
You are currently on the new version of our website. Access the old version .
OncoOnco
  • Article
  • Open Access

1 May 2025

14 Pages

The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation

,
,
,
,
,
,
,
,
…
1
Sports Performance Laboratory, School of Physical Education and Sport Science, National and Kapodistrian University of Athens, 17237 Athens, Greece
2
Flow Cytometry Unit, Department of Biology, National and Kapodistrian University of Athens, 15784 Athens, Greece
3
Department of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece
4
Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, Panepistimiopolis Zografou, National and Kapodistrian University of Athens, 15771 Athens, Greece
This article belongs to the Special Issue Targeting of Tumor Dormancy Pathway

Simple Summary

Multiple myeloma affects the quality of life and physical functioning of patients. In addition, disease progression is affected by the bone marrow microenvironment. The purpose of this study was to investigate the possible relationship between the bone marrow microenvironment and the quality of life/ physical function of multiple myeloma patients after first-line treatment. It was revealed that the percentage of CD27+ NK/NKT cells was correlated positively with physical function and role functioning, and negatively with fatigue, pain, and dyspnea. This suggests that stronger immune surveillance in the bone marrow from CD27+ NK/NKT cells implies a better quality of life in multiple myeloma patients.

Abstract

Background/Objectives: Multiple myeloma is a malignancy of plasma cells detected in the bone marrow, inducing symptoms like anemia, hypercalcemia, renal problems, and bone fractures in multiple myeloma patients, affecting their quality of life. The bone marrow microenvironment plays a crucial role in the prognosis and progression of the disease. The purpose of this study was to examine the relationship between the percentages of the major cell populations of the bone marrow, including immune cells, and physical function/quality of life in multiple myeloma patients after first-line treatment. Methods: Twenty-one multiple myeloma patients (N = 14 men, N = 7 women) participated in the study after completing first-line treatment. Bone marrow and blood samples were taken one hundred days after transplantation, while physical function (6 min walking test, handgrip test, maximal aerobic power, and isometric strength), health-related quality of life (QLQ-C30), and body composition (DXA) were assessed 2–5 days later. Flow cytometry was used to assess the percentages of plasma cells, mast cells, B cells (total, precursors, naïve, and memory), T cells (total, CD27− and CD27+), NK/NKT cells (total, CD27− and CD27+), eosinophils, monocytes, neutrophils, myeloid progenitors, erythroblasts, and erythroid progenitors, expressed as percentages of total nucleated cells of the bone marrow. Results: The percentage of CD27+ NK/NKT cells was correlated with five parameters of the quality of life questionnaire: physical function (r = 0.78, p = 0.005), role functioning (r = 0.69, p = 0.020), fatigue (r = −0.86, p = 0.000), pain (r = 0.68, p = 0.021), and dyspnea (r = −0.80, p = 0.003). Conclusions: In conclusion, stronger immune surveillance in the bone marrow from CD27+ NK/NKT cells is correlated with better quality of life in multiple myeloma patients.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.